Rule register

Drug Enforcement Administration

Rules and guidance in the register from this issuing body: Drug Enforcement Administration.

1 rule

Rules and guidance from Drug Enforcement Administration

  1. 21 CFR 1307.41; 42 CFR 12.1 (Fourth Temporary Extension, 90 FR 61301; Docket No. DEA-407) · Effective (as of November 14, 2026)

    Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

    DEA and HHS extended, through December 31, 2026, the telemedicine flexibilities in place since the COVID-19 public health emergency for prescribing controlled medications. Until then, a DEA-registered practitioner may prescribe schedule II-V controlled substances via telemedicine to a patient without an in-person medical evaluation, if the prescription is for a legitimate medical purpose, uses an interactive telecommunications system and meets the other conditions of 21 CFR 1307.41(c). The rule took effect on January 1, 2026.

    • Drug Enforcement Administration, Department of Health and Human Services
    • Final rule
    • Next: deadline December 31, 2026